BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24236924)

  • 1. Building structure-activity insights through patent mining.
    Tu M; Pfefferkorn JA; Guzman-Perez A; Filipski KJ
    Pharm Pat Anal; 2012 Nov; 1(5):545-54. PubMed ID: 24236924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data structures and computational tools for the extraction of SAR information from large compound sets.
    Wawer M; Lounkine E; Wassermann AM; Bajorath J
    Drug Discov Today; 2010 Aug; 15(15-16):630-9. PubMed ID: 20547243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring sets of molecules from patents and relationships to other active compounds in chemical space networks.
    Kunimoto R; Bajorath J
    J Comput Aided Mol Des; 2017 Sep; 31(9):779-788. PubMed ID: 28871390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target family-directed exploration of scaffolds with different SAR profiles.
    Hu Y; Bajorath J
    J Chem Inf Model; 2011 Dec; 51(12):3138-48. PubMed ID: 22091691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A data mining method to facilitate SAR transfer.
    Wassermann AM; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1857-66. PubMed ID: 21774471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SureChEMBL: a large-scale, chemically annotated patent document database.
    Papadatos G; Davies M; Dedman N; Chambers J; Gaulton A; Siddle J; Koks R; Irvine SA; Pettersson J; Goncharoff N; Hersey A; Overington JP
    Nucleic Acids Res; 2016 Jan; 44(D1):D1220-8. PubMed ID: 26582922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinase patent space visualization using chemical replacements.
    Southall NT; Ajay
    J Med Chem; 2006 Mar; 49(6):2103-9. PubMed ID: 16539399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontology-based content analysis of US patent applications from 2001-2010.
    Weber L; Böhme T; Irmer M
    Pharm Pat Anal; 2013 Jan; 2(1):39-54. PubMed ID: 24236969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An advanced search engine for patent analytics in medicinal chemistry.
    Pasche E; Gobeill J; Teodoro D; Gaudinat A; Vishnykova D; Lovis C; Ruch P
    Stud Health Technol Inform; 2012; 180():204-9. PubMed ID: 22874181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From activity cliffs to activity ridges: informative data structures for SAR analysis.
    Vogt M; Huang Y; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1848-56. PubMed ID: 21761918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graph mining for SAR transfer series.
    Gupta-Ostermann D; Wawer M; Wassermann AM; Bajorath J
    J Chem Inf Model; 2012 Apr; 52(4):935-42. PubMed ID: 22436016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematically evaluating read-across prediction and performance using a local validity approach characterized by chemical structure and bioactivity information.
    Shah I; Liu J; Judson RS; Thomas RS; Patlewicz G
    Regul Toxicol Pharmacol; 2016 Aug; 79():12-24. PubMed ID: 27174420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making every SAR point count: the development of Chemistry Connect for the large-scale integration of structure and bioactivity data.
    Muresan S; Petrov P; Southan C; Kjellberg MJ; Kogej T; Tyrchan C; Varkonyi P; Xie PH
    Drug Discov Today; 2011 Dec; 16(23-24):1019-30. PubMed ID: 22024215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearing the fog: patenting trends for the treatment of Alzheimer's disease.
    Lloyd M; Mokdsi G; Spielthenner D
    Pharm Pat Anal; 2012 Sep; 1(4):437-55. PubMed ID: 24236882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automatic identification of relevant chemical compounds from patents.
    Akhondi SA; Rey H; Schwörer M; Maier M; Toomey J; Nau H; Ilchmann G; Sheehan M; Irmer M; Bobach C; Doornenbal M; Gregory M; Kors JA
    Database (Oxford); 2019 Jan; 2019():. PubMed ID: 30698776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting key example compounds in competitors' patent applications using structural information alone.
    Hattori K; Wakabayashi H; Tamaki K
    J Chem Inf Model; 2008 Jan; 48(1):135-42. PubMed ID: 18177028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substructure mining using elaborate chemical representation.
    Kazius J; Nijssen S; Kok J; Bäck T; Ijzerman AP
    J Chem Inf Model; 2006; 46(2):597-605. PubMed ID: 16562988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global mapping of pharmacological space.
    Paolini GV; Shapland RH; van Hoorn WP; Mason JS; Hopkins AL
    Nat Biotechnol; 2006 Jul; 24(7):805-15. PubMed ID: 16841068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identify drug repurposing candidates by mining the protein data bank.
    Moriaud F; Richard SB; Adcock SA; Chanas-Martin L; Surgand JS; Ben Jelloul M; Delfaud F
    Brief Bioinform; 2011 Jul; 12(4):336-40. PubMed ID: 21768131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classifying patents based on their semantic content.
    Bergeaud A; Potiron Y; Raimbault J
    PLoS One; 2017; 12(4):e0176310. PubMed ID: 28445550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.